Ann Arbor, MI, United States of America

Fong Wang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Warner-Lambert Company. Active years: 2006.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fong Wang: Innovator in Amino Acid Applications

Introduction

Fong Wang is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work involving amino acids. His research focuses on the therapeutic applications of these compounds in treating various disorders.

Latest Patents

Fong Wang holds a patent titled "Methods for using amino acids with affinity for the α2δ-protein." This invention relates to specific β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. These compounds, along with their pharmaceutically acceptable salts, are useful in the treatment of a variety of psychiatric, pain, and other disorders. He has been granted 1 patent for this groundbreaking work.

Career Highlights

Fong Wang has had a successful career at Warner-Lambert Company, where he has been able to apply his research in practical settings. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of new treatments for complex health issues.

Collaborations

Throughout his career, Fong Wang has collaborated with esteemed colleagues, including George M Haig and Denis Schrier. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Fong Wang's contributions to the field of pharmaceuticals through his innovative use of amino acids demonstrate his commitment to improving health outcomes. His work continues to influence the development of new treatments for various disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…